No abstract

In Germany and France, where there is still limited out-of-pocket health spending, the majority of sampled respondents stated that they would purchase meningococcal vaccines with their own money.

No abstract

Content analysis and evaluation of missing data led to exclusion of 'Menstrual symptoms' and 'Sexual behavior' domains, retaining these as optional modules of the core questionnaire. Additionally, item 13 was excluded because it does not investigate the same concepts as other domains and the deletion of five additional items appeared to improve the questionnaire's factor structure. The revised WHQ comprises 23 items, investigating six domains. The cross-sectional psychometric properties of the 23-item WHQ were good and better than those of the 36-item version. The 23-item WHQ was assessed with multinational data, to evaluate cross-cultural equivalence of linguistically adapted versions. In addition, its reproducibility and responsiveness need to be documented.

This paper summarises the results of an investigation of willingness to pay (WTP) for new vaccines. The vaccines considered are for infections with several subtypes. One option is to cover a broad combination of these within one vaccine although this is associated with additional development complexities. The associated durations of effect of such vaccines are not yet known; therefore the impact of variations in this and the subtype coverage, as well as that of opting for a non-reimbursement status, were among the issues that needed to be assessed. One important group for a determination of WTP is parents, in that they could be paying for vaccination of themselves and/or their children. This paper reports the findings of WTP among this group for their children for alternative outcomes in the vaccine product profile. For reasons of confidentiality, results from only this group in the context of paying for their children are reported. The exact wording of the product features tested have also been changed for the same reason.